T1	PROC 46 55	Protocolo
#1	AnnotatorNotes T1	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T2	PROC 69 85	ensayos clínicos
#2	AnnotatorNotes T2	C0008976; Clinical Trials; Research Activity
T3	DISO 97 111	macrotrombosis
T4	DISO 113 133	microinmunotrombosis
T5	DISO 135 160	hiperinflamación vascular
T6	DISO 163 182	hipercoagulabilidad
#3	AnnotatorNotes T6	C0398623; Thrombophilia; Disease or Syndrome
T7	ANAT 188 227	sistema renina-angiotensina-aldosterona
#4	AnnotatorNotes T7	C0086907; Renin-Angiotensin-Aldosterone System; Body System
T8	ANAT 229 233	SRAA
#5	AnnotatorNotes T8	C0086907; Renin-Angiotensin-Aldosterone System; Body System | C0228062; Reticular activating system; Body System
T9	LIVB 238 247	pacientes
#6	AnnotatorNotes T9	C0030705; Patients; Patient or Disabled Group
T10	PROC 248 262	hospitalizados
#7	AnnotatorNotes T10	C0019993; Hospitalization; Health Care Activity
T11	DISO 267 275	COVID-19
#8	AnnotatorNotes T11	C5203670; COVID19 (disease); Disease or Syndrome
T12	DISO 299 330	Infección por el virus COVID-19
T13	PROC 360 375	Hospitalización
#9	AnnotatorNotes T13	C0019993; Hospitalization; Health Care Activity
T14	DISO 380 388	COVID-19
#10	AnnotatorNotes T14	C5203670; COVID19 (disease); Disease or Syndrome
T15	Age 392 400	≥18 años
T16	DISO 412 436	Infección por SARS-CoV-2
#11	AnnotatorNotes T16	C5203670; COVID19 (disease); Disease or Syndrome
T17	PROC 462 486	prueba de ácido nucleico
#12	AnnotatorNotes T17	C0200932; Nucleic Acid Amplification Tests; Laboratory Procedure
T18	PROC 488 491	NAT
#13	AnnotatorNotes T18	C0200932; Nucleic Acid Amplification Tests; Laboratory Procedure
T19	Duration 519 529	los 3 días
T20	PROC 546 560	aleatorización
#14	AnnotatorNotes T20	C0034656; Randomization; Research Activity
T21	PROC 585 588	NAT
#15	AnnotatorNotes T21	C0200932; Nucleic Acid Amplification Tests; Laboratory Procedure
T22	PROC 591 598	pruebas
#16	AnnotatorNotes T22	C1510438; Assay; Laboratory Procedure
T23	Duration 612 625	más de 3 días
T24	PROC 638 652	aleatorización
#17	AnnotatorNotes T24	C0034656; Randomization; Research Activity
T25	DISO 655 676	enfermedad progresiva
T26	DISO 689 713	infección por SARS-CoV-2
#18	AnnotatorNotes T26	C5203670; COVID19 (disease); Disease or Syndrome
T27	Date 714 722	en curso
T28	LIVB 732 756	investigador responsable
T29	PROC 767 774	pruebas
#19	AnnotatorNotes T29	C1510438; Assay; Laboratory Procedure
T30	PROC 789 792	NAT
#20	AnnotatorNotes T30	C0200932; Nucleic Acid Amplification Tests; Laboratory Procedure
T31	PROC 874 877	NAT
#21	AnnotatorNotes T31	C0200932; Nucleic Acid Amplification Tests; Laboratory Procedure
T32	PROC 896 905	protocolo
#22	AnnotatorNotes T32	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T33	PROC 961 968	pruebas
#23	AnnotatorNotes T33	C1510438; Assay; Laboratory Procedure
T34	Neg_cue 969 978	distintas
T35	PROC 983 986	NAT
#24	AnnotatorNotes T35	C0200932; Nucleic Acid Amplification Tests; Laboratory Procedure
T36	DISO 1003 1012	Hipoxemia
#25	AnnotatorNotes T36	C0700292; Hypoxemia; Finding
T37	PROC 1028 1032	SpO2
T38	CHEM 1078 1085	oxígeno
#26	AnnotatorNotes T38	C0030054; oxygen; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T39	PROC 1086 1099	suplementario
T40	PROC 1117 1121	SpO2
T41	CHEM 1142 1149	oxígeno
#27	AnnotatorNotes T41	C0030054; oxygen; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T42	PROC 1150 1163	suplementario
T43	PROC 1181 1185	SpO2
T44	LIVB 1200 1208	paciente
#28	AnnotatorNotes T44	C0030705; Patients; Patient or Disabled Group
T45	PROC 1213 1244	tratamiento crónico con oxígeno
T46	Duration 1225 1232	crónico
T47	DISO 1248 1256	Síntomas
#29	AnnotatorNotes T47	C1457887; Symptoms; Sign or Symptom
T48	DISO 1259 1265	signos
#30	AnnotatorNotes T48	C0311392; Physical findings; Finding
T49	DISO 1269 1277	COVID-19
#31	AnnotatorNotes T49	C5203670; COVID19 (disease); Disease or Syndrome
T50	DISO 1332 1335	tos
#32	AnnotatorNotes T50	C0010200; Coughing; Sign or Symptom
T51	PROC 1339 1359	temperatura corporal
T52	DISO 1419 1425	fatiga
#33	AnnotatorNotes T52	C0015672; Fatigue; Sign or Symptom
T53	DISO 1427 1433	disnea
#34	AnnotatorNotes T53	C0013404; Dyspnea; Sign or Symptom
T54	DISO 1436 1452	falta de aliento
#35	AnnotatorNotes T54	C0013404; Dyspnea; Sign or Symptom
T55	DISO 1457 1471	dolor torácico
#36	AnnotatorNotes T55	C0008031; Chest Pain; Sign or Symptom
T56	DISO 1475 1486	infiltrados
#37	AnnotatorNotes T56	C0332448; Infiltration; Pathologic Function
T57	PROC 1494 1511	imágenes de tórax
T58	PROC 1513 1524	radiografía
#38	AnnotatorNotes T58	C1306645; Plain x-ray; Diagnostic Procedure | C1962945; Radiographic imaging procedure; Diagnostic Procedure
T59	PROC 1526 1529	TAC
#39	AnnotatorNotes T59	C0040405; X-Ray Computed Tomography; Diagnostic Procedure
T60	PROC 1531 1549	ecografía pulmonar
T61	DISO 1597 1617	síntomas de COVID-19
T62	Duration 1618 1626	>14 días
T63	PROC 1639 1653	aleatorización
#40	AnnotatorNotes T63	C0034656; Randomization; Research Activity
T64	PROC 1657 1670	Hospitalizado
#41	AnnotatorNotes T64	C0019993; Hospitalization; Health Care Activity
T65	Duration 1679 1688	>72 horas
T66	PROC 1701 1715	aleatorización
#42	AnnotatorNotes T66	C0034656; Randomization; Research Activity
T67	PHYS 1719 1727	Embarazo
#43	AnnotatorNotes T67	C0032961; Pregnancy; Organism Function
T68	PHYS 1731 1740	Lactancia
#44	AnnotatorNotes T68	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T69	LIVB 1744 1755	Prisioneros
T70	DISO 1759 1784	Enfermedad renal terminal
#45	AnnotatorNotes T70	C0022661; Kidney Failure, Chronic; Disease or Syndrome
T71	DISO 1786 1789	ERT
T72	PROC 1794 1802	diálisis
#46	AnnotatorNotes T72	C4551529; Renal Dialysis; Therapeutic or Preventive Procedure
T73	LIVB 1809 1817	paciente
#47	AnnotatorNotes T73	C0030705; Patients; Patient or Disabled Group
T74	Neg_cue 1840 1842	no
T75	PROC 1863 1881	tratamiento médico
#48	AnnotatorNotes T75	C0418981; Medical therapy; Therapeutic or Preventive Procedure
T76	Negated 1863 1881	tratamiento médico
T77	Negated 1882 1890	completo
T78	LIVB 1898 1906	paciente
#49	AnnotatorNotes T78	C0030705; Patients; Patient or Disabled Group
T79	Neg_cue 1925 1927	No
T80	PROC 1928 1936	reanimar
#50	AnnotatorNotes T80	C0035273; Resuscitation procedure; Therapeutic or Preventive Procedure
T81	Negated 1928 1936	reanimar
T82	Neg_cue 1941 1947	impida
T83	PROC 1952 1974	compresiones del tórax
T84	Negated 1952 1974	compresiones del tórax
T85	DISO 1986 2001	parada cardiaca
#51	AnnotatorNotes T85	C0018790; Cardiac Arrest; Disease or Syndrome
T86	PROC 2040 2058	tratamiento médico
#52	AnnotatorNotes T86	C0418981; Medical therapy; Therapeutic or Preventive Procedure
T87	LIVB 2102 2120	médico responsable
T88	PROC 2125 2136	tratamiento
#53	AnnotatorNotes T88	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T89	Neg_cue 2149 2165	incapacidad para
T90	Negated 2166 2198	participar en los procedimientos
T91	PROC 2184 2198	procedimientos
T92	Negated 2216 2229	participación
T93	Neg_cue 2230 2232	no
T94	Negated 2239 2244	mejor
T95	LIVB 2253 2261	paciente
#54	AnnotatorNotes T95	C0030705; Patients; Patient or Disabled Group
T96	CHEM 2311 2323	fostamatinib
T97	PROC 2328 2340	Aleatorizado
#55	AnnotatorNotes T97	C0034656; Randomization; Research Activity
T98	CHEM 2367 2379	fostamatinib
T99	Duration 2383 2405	los 30 días anteriores
T100	CHEM 2454 2466	fostamatinib
T101	Duration 2485 2497	las 24 horas
T102	PROC 2511 2525	aleatorización
#56	AnnotatorNotes T102	C0034656; Randomization; Research Activity
T103	PROC 2530 2533	AST
#57	AnnotatorNotes T103	C0201899; Aspartate aminotransferase measurement; Laboratory Procedure
T104	PROC 2536 2539	ALT
#58	AnnotatorNotes T104	C0201836; Alanine aminotransferase measurement; Laboratory Procedure
T105	PROC 2587 2590	ALT
#59	AnnotatorNotes T105	C0201836; Alanine aminotransferase measurement; Laboratory Procedure
T106	PROC 2593 2596	AST
#60	AnnotatorNotes T106	C0201899; Aspartate aminotransferase measurement; Laboratory Procedure
T107	PROC 2609 2626	bilirrubina total
#61	AnnotatorNotes T107	C0201913; Bilirubin, total measurement; Laboratory Procedure
T108	PROC 2640 2643	PAS
#62	AnnotatorNotes T108	C0031067; Periodic Acid-Schiff Reaction; Laboratory Procedure | C1306620; Systolic blood pressure measurement; Diagnostic Procedure
T109	PROC 2657 2660	PAD
#63	AnnotatorNotes T109	C1305849; Diastolic blood pressure measurement; Diagnostic Procedure
T110	PROC 2707 2721	aleatorización
#64	AnnotatorNotes T110	C0034656; Randomization; Research Activity
T111	PROC 2725 2728	RAN
#65	AnnotatorNotes T111	C0948762; Absolute neutrophil count; Laboratory Procedure
T112	LIVB 2745 2753	paciente
#66	AnnotatorNotes T112	C0030705; Patients; Patient or Disabled Group
T113	CHEM 2773 2802	moduladores potentes de CYP3A
T114	CHEM 2825 2839	claritromicina
#67	AnnotatorNotes T114	C0055856; clarithromycin; Antibiotic · Organic Chemical
T115	CHEM 2841 2850	indinavir
#68	AnnotatorNotes T115	C0376637; indinavir; Organic Chemical · Pharmacologic Substance
T116	CHEM 2852 2863	itraconazol
#69	AnnotatorNotes T116	C0064113; itraconazole; Organic Chemical · Pharmacologic Substance
T117	CHEM 2865 2876	ketoconazol
#70	AnnotatorNotes T117	C0022625; ketoconazole; Organic Chemical · Pharmacologic Substance
T118	CHEM 2878 2888	nefazodona
#71	AnnotatorNotes T118	C0068485; nefazodone; Organic Chemical · Pharmacologic Substance
T119	CHEM 2890 2900	nelfinavir
#72	AnnotatorNotes T119	C0525005; nelfinavir; Organic Chemical · Pharmacologic Substance
T120	CHEM 2902 2911	ritonavir
#73	AnnotatorNotes T120	C0292818; ritonavir; Organic Chemical · Pharmacologic Substance
T121	CHEM 2913 2923	saquinavir
#74	AnnotatorNotes T121	C0286738; saquinavir; Organic Chemical · Pharmacologic Substance
T122	CHEM 2925 2938	telitromicina
#75	AnnotatorNotes T122	C0907410; telithromycin; Antibiotic · Organic Chemical
T123	CHEM 2940 2955	troleandomicina
#76	AnnotatorNotes T123	C0041165; troleandomycin; Antibiotic · Organic Chemical
T124	CHEM 2957 2970	carbamazepina
#77	AnnotatorNotes T124	C0006949; carbamazepine; Organic Chemical · Pharmacologic Substance
T125	CHEM 2972 2981	efavirenz
#78	AnnotatorNotes T125	C0674428; efavirenz; Organic Chemical · Pharmacologic Substance
T126	CHEM 2983 2995	enzalutamida
#79	AnnotatorNotes T126	C3496793; enzalutamide; Organic Chemical · Pharmacologic Substance
T127	CHEM 2997 3007	modafinilo
#80	AnnotatorNotes T127	C0066677; modafinil; Organic Chemical · Pharmacologic Substance
T128	CHEM 3009 3019	nevirapina
#81	AnnotatorNotes T128	C0132326; nevirapine; Organic Chemical · Pharmacologic Substance
T129	CHEM 3021 3034	oxcarbazepina
#82	AnnotatorNotes T129	C0069751; oxcarbazepine; Organic Chemical · Pharmacologic Substance
T130	CHEM 3036 3048	fenobarbital
#83	AnnotatorNotes T130	C0031412; phenobarbital; Organic Chemical · Pharmacologic Substance
T131	CHEM 3050 3059	fenitoína
#84	AnnotatorNotes T131	C0031507; phenytoin; Organic Chemical · Pharmacologic Substance
T132	CHEM 3061 3071	rifabutina
#85	AnnotatorNotes T132	C0140575; rifabutin; Antibiotic · Organic Chemical
T133	CHEM 3074 3085	rifampicina
#86	AnnotatorNotes T133	C0035608; rifampin; Antibiotic · Organic Chemical
T134	CHEM 3087 3105	hierba de San Juan
T135	CHEM 3108 3120	troglitazona
#87	AnnotatorNotes T135	C0245514; troglitazone; Organic Chemical · Pharmacologic Substance
T136	LIVB 3129 3137	paciente
#88	AnnotatorNotes T136	C0030705; Patients; Patient or Disabled Group
T137	Neg_cue 3138 3140	no
T138	Negated 3141 3157	puede participar
T139	Neg_cue 3160 3167	rechaza
T140	Negated 3168 3178	participar
T141	CHEM 3194 3206	fostamatinib
